跳至主要内容
临床试验/NCT06406244
NCT06406244招募中不适用

Efficacy of Transcutaneous Electrical Acupoint Stimulation on Chronic Pain and Survival in Patients Undergoing Hepatectomy: a Prospective, Randomized Controlled Trial

West China Hospital1 个研究点 分布在 1 个国家目标入组 524 人开始时间: 2024年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
524
试验地点
1
主要终点
The incidence of chronic pain at 3 months postoperatively

研究概览

简要总结

This study is a further observation and follow-up of the patients enrolled in the registration number NCT06341270 to further evaluate the efficacy of TEAS on postoperative chronic pain, quality of life and survival rate in patients undergoing hepatectomy.

详细描述

This study is a further observation and follow-up of the patients enrolled in the registration number NCT06341270 to further evaluate the efficacy of TEAS on postoperative chronic pain and survival in patients undergoing hepatectomy. Patients who meet the enrollment criteria will be randomized 1:1 to either the transcutaneous electrical acupoint stimulation (TEAS)or the sham groups. In the TEAS group, the acupoints are bilateral neiguan (PC6), Hegu (L14), Yanglingquan (GB34), Zusanli (ST 36) and Renying (ST9) acupoints. Patients will receive TEAS 30 min before anesthesia until being discharged from the post-anaesthesia care unit (PACU). The same treatment for 30 min will be performed on the 1st, 2nd and 3rd days after surgery. The stimulation intensity will be adjusted in accordance with the maximal level tolerated by each patient. Patients in the sham group will receive electrode attachment but without stimulation. Follow-up after discharge includes chronic pain, the impact of chronic pain on quality of life, the relapse-free survival, overall survival at 3 months and 6 months postoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Blinding of participants will be maintained throughout the observation period. The sham group will receive electrode attachment but without stimulation. Throughout the study, for adequate blinding, an opaque tape will be applied to the patient's skin above the electrodes, and the patient's target acupoints will be wrapped in a blanket. All patients will be informed that they might or might not feel a tingling sensation around the acupoints when the TEAS device is working. The patients should not be unblinded until the statistical analysis of the study data is completed.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years old; ASA physical status classⅠ-Ⅲ; Patients scheduled for elective hepatectomy.

排除标准

  • Have a history of epilepsy; Rash or local infection over the acupoint stimulation skin area; Pregnancy or breastfeeding; Mental retardation, psychiatric, or neurological disease; Inability to comprehend the numeric rating scale (NRS); Implantation of a cardiac pacemaker, cardioverter, or defibrillator; Chronic opioid use; Metastases in other organs.

结局指标

主要结局

The incidence of chronic pain at 3 months postoperatively

时间窗: 3 months postoperatively

Chronic pain is defined as pain that lasts or recurs for longer than 3 months. For chronic postsurgical pain(CPSP), it mainly refers to the pain that persists past normal healing time. Pain scoring is performed at 3 months using the Numerical Rating Scale(NRS), with 11 digits ranging from 0 to 10 indicating the degree of pain, 0 indicating no pain, and 10 indicating severe pain. Subjects choose a number to indicate the degree of pain based on their personal pain experience.

次要结局

  • The sleep quality score postoperatively(Up to 6 months postoperatively)
  • The incidence of chronic pain at 6 months(6 months postoperatively)
  • Quality of Recovery Scale Score postoperatively(Up to 6 months postoperatively)
  • Overall survival postoperatively(Up to 6 months postoperatively)
  • Disability-free survival postoperatively(Up to 6 months postoperatively)
  • Brief Pain Inventory(BPI) pain interference subscale score(Up to 6 months postoperatively)
  • Recurrence-free survival postoperatively(Up to 6 months postoperatively)
  • The prevalence of neuropathic pain(Up to 6 months postoperatively)
  • The anxiety and depression scores postoperatively(Up to 6 months postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chunling Jiang

Professor

West China Hospital

研究点 (1)

Loading locations...

相似试验